Advertisement
Review article| Volume 22, ISSUE 1, P99-131, February 2004

Pseudotumor cerebri

      Pseudotumor cerebri (PTC) is a perplexing syndrome of increased intracranial pressure (ICP) without a space-occupying lesion. The terminology for the disorder has changed over the years and the diagnostic criteria revised to reflect advances in diagnostic technology and insights into the disease process [
      • Friedman D.I
      • Jacobson D.M
      Diagnostic criteria for idiopathic intracranial hypertension.
      ]. The classification and nomenclature depend on the presence or absence of an underlying cause. When the diagnostic criteria are followed, a secondary etiology is unlikely (Box 1[
      • Friedman D.I
      • Jacobson D.M
      Diagnostic criteria for idiopathic intracranial hypertension.
      ]). When no secondary cause is identified, the syndrome is termed “idiopathic intracranial hypertension (IIH).”
      Diagnostic criteria for pseudotumor cerebri
      • Symptoms, if present, reflect only those of increased intracranial pressure or papilledema.
      • Signs are attributable only to increased intracranial pressure or papilledema.
      • Documented elevated intracranial pressure during lumbar puncture is measured in the lateral decubitus position.
      • Cerebrospinal fluid composition is normal.
      • There is no ventriculomegaly, mass, structural, or vascular lesion on neuroimaging studies (ie, MRI or contrast-enhanced CT for typical patients, and MRI and magnetic resonance venography for all others).
      • If no other cause (including medication) of intracranial hypertension is identified, the syndrome is termed “idiopathic intracranial hypertension.”
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Neurologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Friedman D.I
        • Jacobson D.M
        Diagnostic criteria for idiopathic intracranial hypertension.
        Neurology. 2002; 59: 1492-1495
        • Durcan F.J
        • Corbett J.J
        • Wall M
        The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana.
        Arch Neurol. 1988; 45: 875-877
        • Kesler A
        • Gadoth N
        Epidemiology of idiopathic intracranial hypertension in Israel.
        J Neuroophthalmol. 2001; 21: 12-14
        • Radhakrishanan K
        • Ahlskog J.E
        • Cross S.A
        • et al.
        Idiopathic intracranial hypertension (pseudotumor cerebri). Descriptive epidemiology in Rochester, Minn, 1976–1990.
        Arch Neurol. 1993; 50: 78-80
        • Radhakrishanan K
        • Sridharan R
        • Askhok P.P
        • et al.
        Pseudotumor cerebri: incidence and pattern in north-eastern Libya.
        Acta Neurol (Napoli). 1986; 25: 117
        • Balcer L.J
        • Liu G.T
        • Forman S
        • et al.
        Idiopathic intracranial hypertension: relation of age and obesity in children.
        Neurology. 1999; 52: 870-872
        • Gordon K
        Pediatric pseudotumor cerebri: descriptive epidemiology.
        Can J Neurol Sci. 1997; 24: 219-221
        • Scott I.U
        • Siatkowski R.M
        • Eneyni M
        • et al.
        Idiopathic intracranialhypertension in children and adolescents.
        Am J Ophthalmol. 1997; 124: 253-255
        • Bandyopadhyay S
        • Jacobson D.M
        Clinical features of late life-onset pseudotumor cerebri fulfilling the Modified Dandy Criteria.
        J Neuroophthalmol. 2002; 22: 9-11
        • Celebisoy N
        • Secil Y
        • Akyurekli O
        Pseudotumor cerebri: etiological factors, presenting features and prognosis in the western part of Turkey.
        Acta Neurol Scand. 2002; 106: 367-370
        • Wall M
        • George D
        Idiopathic intracranial hypertension. A prospective study of 50 patients.
        Brain. 1991; 114: 155-180
        • Weig S.G
        Asymptomatic idiopathic intracranial hypertension in young children.
        J Child Neurol. 2002; 17: 239-241
        • Giuseffi V
        • Wall M
        • Spiegel P.Z
        • et al.
        Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study.
        Neurology. 1991; 41: 239-244
        • Round R
        • Keane J.R
        The minor symptoms of increased intracranial pressure: 101 patients with benign intracranial hypertension.
        Neurology. 1988; 38: 1461-1464
        • Friedman D.I
        • Rausch E.A
        Headache diagnoses in patients with treated idiopathic intracranial hypertension.
        Neurology. 2002; 58: 1551-1553
        • Ramadan N.M
        Intracranial hypertension and migraine.
        Cephalalgia. 1993; 13: 210-211
        • Wang S.-J
        • Silberstein S.D
        • Patterson S
        • et al.
        Idiopathic intracranial hypertension without papilledema. A case-control study in a headache center.
        Neurology. 1998; 51: 245-249
        • Sadun A.A
        • Currie J
        • Lessell S
        Transient visual obscurations with elevated optic discs.
        Ann Neurol. 1984; 16: 489-494
        • Corbett J.J
        • Savino P.J
        • Thompson H.S
        • et al.
        Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss.
        Arch Neurol. 1982; 39: 461-474
        • Rush J.A
        Pseudotumor cerebri: Clinical profile and visual outcome in 63 patients.
        Mayo Clin Proc. 1980; 55: 541-546
        • Meador K.J
        • Swift T.R
        Tinnitus from intracranial hypertension.
        Neurology. 1984; 34: 1258-1261
        • Sismanis A
        Otologic manifestations of benign intracranial hypertension syndrome: diagnosis and management.
        Laryngoscope. 1987; 97: 1-17
        • Fishman R.A
        Anatomical aspects of the cerebrospinal fluid.
        in: Fishman R Cerebrospinal fluid in diseases of the nervous system. W.B. Saunders, Philadelphia1992: 20
        • Dorman P.J
        • Campbell M.J
        Hearing loss as a false localising sign in raised intracranial pressure.
        J Neurol Neurosurg Psychiatry. 1995; 58: 516
        • Sismanis A
        • Hughes G.B
        • Abedi E
        • et al.
        Otologic symptoms and findings of the pseudotumor cerebri syndrome: a preliminary report.
        Otolaryngol Head Neck Surg. 1985; 93: 398-402
        • Capobianco D.J
        • Brazis P.W
        • Cheshire W.P
        Idiopathic intracranial hypertension and seventh nerve palsy.
        Headache. 1997; 37: 286-288
        • Bortoluzzi M
        • Di Lauro L
        • Marini G
        Benign intracranial hypertension with spinal and radicular pain.
        J Neurosurg. 1982; 57: 833-836
        • Groves M.D
        • McCutcheon I.E
        • Ginsberg L.E
        • et al.
        Radicular pain can be a symptom of elevated intracranial pressure.
        Neurology. 1999; 52: 1093-1095
        • Murray R.S
        • Tait V.F
        • Thompson J.A
        Spinal and radicular pain in pseudotumor cerebri.
        Pediatr Neurol. 1986; 2: 106-107
        • Selky A.K
        • Dobyns W.B
        • Yee R.D
        Idiopathic intracranial hypertension and facial diplegia.
        Neurology. 1994; 44: 357
        • Kleinschmidt J.J
        • Digre K.B
        • Hanover R
        Idiopathic intracranial hypertension. Relationship to depression, anxiety, and quality of life.
        Neurology. 2000; 54: 319-324
        • Ross D.R
        • Coffey C.E
        • Massey E.W
        • et al.
        Depression and benign intracranial hypertension.
        Psychosomatics. 1985; 26: 387-389
        • Kaplan C.P
        • Miner M.E
        • McGregor J.M
        Pseudotumor cerebri: risk for cognitive impairment?.
        Brain Inj. 1997; 11: 293-303
        • Wall M
        • White II, W.N
        Asymmetric papilledema in idiopathic intracranial hypertension. Prospective interocular comparison of sensory visual function.
        Invest Ophthalmol Vis Sci. 1998; 39: 132-142
        • Marcelis J
        • Silberstein S.D
        Idiopathic intracranial hypertension without papilledema.
        Arch Neurol. 1991; 48: 392-399
        • Spence J.D
        • Amacher A.L
        • Willis N.R
        Benign intracranial hypertension without papilledema: role of 24-hour cerebrospinal fluid pressure monitoring in diagnosis and management.
        Neurosurgery. 1980; 7: 326-336
        • Orcutt J.C
        • Page N.G.R
        • Sanders M.D
        Factors affecting visual loss in benign intracranial hypertension.
        Ophthalmology. 1984; 91: 1303-1312
        • Wall M
        • George D
        Visual loss in pseudotumor cerebri: incidence and defects related to visual field strategy.
        Arch Neurol. 1987; 44: 170-175
        • Griebel S.R
        • Kosmorsky G.S
        Choroidal folds associated with increased intracranial pressure.
        Am J Ophthalmol. 2000; 129: 513-516
        • Frisén L
        Swelling of the optic nerve head: a staging scheme.
        J Neurol Neurosurg Psychiatry. 1982; 45: 13-18
        • Shuper A
        • Snir M
        • Barash D
        • et al.
        Ultrasonography of the optic nerves: clinical application in children with pseudotumor cerebri.
        J Pediatr. 1997; 131: 734-740
        • Walsh T.J
        • Garden J.W
        • Gallangher B
        Obliteration of retinal venous pulsations.
        Am J Ophthalmol. 1969; 67: 954-956
        • Verplanck M
        • Kaufman D.I
        • Parsons T
        • et al.
        Electrophysiology versus psychophysics in the detection of visual loss in pseudotumor cerebri.
        Neurology. 1988; 38: 1789-1792
        • Wall M
        Contrast sensitivity in pseudotumor cerebri.
        Ophthalmology. 1986; 93: 4-7
        • Baker R.S
        • Buncic J.R
        Vertical ocular motility disturbances in pseudotumor cerebri.
        J Clin Neuroophthalmol. 1985; 5: 41-44
        • Frohman L.P
        • Kupersmith M.J
        Reversible vertical ocular deviations associated with raised intracranial pressure.
        J Clin Neuroophthalmol. 1985; 5: 158-163
        • Merikangas J.R
        Skew deviation in pseudotumor cerebri.
        Ann Neurol. 1978; 4: 583
        • Friedman D.I
        • Forman S
        • Levi L
        • et al.
        Unusual ocular motility disturbances with increased intracranial pressure.
        Neurology. 1998; 50: 1893-1896
        • Snyder D.A
        • Frankel M
        An unusual presentation of pseudotumor cerebri.
        Ann Ophthalmol. 1979; 11: 1823-1827
        • Weisberg L.A
        Computed tomography in benign intracranial hypertension.
        Neurology. 1985; 35: 1075
        • Jacobson D.M
        • Karanjia P.N
        • Olson K.A
        • et al.
        Computed tomography ventricular size has no predictive value in diagnosing pseudotumor cerebri.
        Neurology. 1990; 40: 1454-1455
        • Zagardo M.T
        • Cail W.S
        • Kelman S.E
        • et al.
        Reversible empty sella in idiopathic intracranial hypertension: an indicator of successful therapy?.
        AJNR Am J Neuroradiol. 1996; 17: 1953-1956
        • Brodsky M.C
        • Vaphiades M
        Magnetic resonance imaging in pseudotumor cerebri.
        Ophthalmology. 1998; 105: 1686-1693
        • Gass A
        • Barker G.J
        • Riordan-Eva P
        • et al.
        MRI of the optic nerve in benign intracranial hypertension.
        Neuroradiology. 1996; 38: 769-773
        • Jinkins J.R
        • Zthale S
        • Xiong A
        • et al.
        MR of the optic papilla protrusion in patients with high intracranial pressure.
        AJNR. 1996; 17: 665-668
        • Sinclair N
        • Asaad N
        • Johnston I
        Pseudotumor cerebri occurring in association with the Chiari malformation.
        J Clin Neurosci. 2002; 9: 99-101
        • Lam B.L
        • Schatz N.J
        • Glaser J.S
        • et al.
        Pseudotumor cerebri from cranial venous obstruction.
        Ophthalmology. 1992; 99: 706-712
        • Cremer P.D
        • Thompson E.O
        • Johnston I.H
        • et al.
        Pseudotumor cerebri and cerebral venous hypertension.
        Neurology. 1996; 47: 1602-1603
        • King J.O
        • Mitchell P.J
        • Thomson K.R
        • et al.
        Cerebral venography and manometry in idiopathic intracranial hypertension.
        Neurology. 1995; 45: 2224-2228
        • Farb R.I
        • Vanek I
        • Scott J.N
        • et al.
        Idiopathic intracranial hypertension. The prevalence and morphology of sinovenous stenosis.
        Neurology. 2003; 60: 1418-1424
        • Ecker A
        Irregular fluctuation of elevated cerebrospinal fluid pressure.
        Arch Neurol Psychiatry. 1955; 74: 641-649
        • Khandhar S
        • Friedman D.I
        Cerebrospinal fluid measurements in patients experiencing severe, benign headaches.
        Headache. 2003; 43: 553
        • Quinckne H
        Uber meningitis serosa and verewandte zustande.
        Dtsch Z Nervenheilkd. 1897; 9: 149
        • Joynt R.J
        • Sahs A.L
        Brain swelling of unknown cause.
        Neurology. 1956; 6: 801-803
        • Wall M
        • Dollar J.D
        • Sadun A.A
        • et al.
        Idiopathic intracranial hypertension. Lack of histological evidence for cerebral edema.
        Arch Neurol. 1995; 52: 141-145
        • Gideon P
        • Sorensen P.S
        • Thompsen C
        • et al.
        Increased brain water self-diffusion in patients with idiopathic intracranial hypertension.
        AJNR. 1995; 16: 381-387
        • Moser F.G
        • Hilal S.K
        • Abrams G
        • et al.
        MR imaging of pseudotumor cerebri.
        Am J Radiol. 1988; 150: 903-909
        • Sorensen P
        • Thomsen C
        • Gjerris F
        • et al.
        Increased brain water content in pseudotumor cerebri measured by magnetic imaging of the brain water self diffusion.
        Neurol Res. 1989; 11: 160-164
        • Connolly M.B
        • Farrell K
        • Hill A
        • et al.
        Magnetic resonance imaging in pseudotumor cerebri.
        Dev Med Child Neurol. 1992; 34: 1091-1094
        • Johnston I
        The definition of a reduced CSF absorption syndrome: a reappraisal of benign intracranial pressure and related conditions.
        Med Hypothesis. 1975; 1: 10-14
        • Karahalios D.G
        • Rekate H.L
        • Khayata M.H
        • et al.
        Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies.
        Neurology. 1996; 46: 198-202
        • King J.O
        • Mitchell P.J
        • Thomson K.R
        • et al.
        Manometry combined with cervical puncture in idiopathic intracranial hypertension.
        Neurology. 2002; 58: 26-30
        • Biousse V
        • Ameri A
        • Bousser M.-G
        Isolated intracranial hypertension as the only sign of cerebral venous thrombosis.
        Neurology. 1999; 53: 1537-1542
        • Daif A
        • Awada A
        • Al-Rajeh S
        • et al.
        Cerebral venous thrombosis in adults: a study of 40 cases from Saudi Arabia.
        Stroke. 1995; 26: 1193-1195
        • Purvin V.A
        • Trobe J.D
        • Kosmorsky G
        Neuro-ophthalmic features of cerebral venous obstruction.
        Arch Neurol. 1995; 52: 880-885
        • Quattrone A
        • Bono F
        • Oliveri R
        • et al.
        Cerebral venous thrombosis and isolated intracranial hypertension without papilledema in CDH.
        Neurology. 2001; 57: 31-36
        • Corbett J.J
        • Digre K.B
        Idiopathic intracranial hypertension. An answer to, “the chicken or the egg?”.
        Neurology. 2002; 58: 5-6
        • Sugarman H.J
        • DeMaria E.J
        • Felton W.L
        • et al.
        Increased intra-abdominal pressure and cardiac filling pressure in obesity-associated pseudotumor cerebri.
        Neurology. 1997; 49: 507-511
        • Digre K.B
        • Varner M.W
        • Corbett J.J
        Pseudotumor cerebri and pregnancy.
        Neurology. 1984; 34: 721-729
        • Lindvall M
        • Edvinsson L
        • Owman C
        Effect of sympathomimetic drugs and corresponding receptor antagonists on the rate of cerebrospinal fluid production.
        Exp Neurol. 1979; 64: 132-145
        • Lindvall M
        • Edvinsson L
        • Owman C
        Reduced cerebrospinal fluid formation through cholinergic mechanisms.
        Neurosci Lett. 1978; 9: 77
        • Lindvall M
        • Owman C
        Autonomic nerves in the mammalian choroid plexus and their influence on the formation of cerebrospinal fluid.
        J Cereb Blood Flow Metab. 1981; 1: 245-246
        • Nilsson C
        • Lindvall-Axelsson M
        • Owman C
        Sympathetic nervous control of cerebrospinal fluid production from the choroid plexus.
        Science. 1978; 201: 176-178
        • Hoffman B.J
        • Mezey E
        Distribution of the serotonin 5-HT1C receptor mRNA in the adult rat brain.
        FEBS Lett. 1989; 247: 453-462
        • Pazos A
        • Baker R.S
        • Khorram D
        • et al.
        The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.
        Eur J Pharmacol. 1985; 106: 539-546
        • Lindvall-Axelsson M
        • Nilsson C
        • Owman C
        • et al.
        Involvement of 5-HT1C receptors in the production of CSF from the choroid plexus.
        in: Seylaz J.M Mac Kenzie E.T Neurotransmission and cerebrovascular function I. Elsevier, Amsterdam1989: 237
        • Friedman D.I
        • Ingram P
        • Rogers M.A.M
        Low tyramine diet in the treatment of idiopathic intracranial hypertension. A pilot study.
        Neurology. 1998; 50: A5
        • Fishman R
        Polar bear liver, vitamin A, aquaporins, and pseudotumor cerebri.
        Ann Neurol. 2002; 52: 531-533
        • Wintour E.M
        Water channels and urea transporters.
        Clin Exp Pharmacol Physiol. 1997; 24: 1-9
        • King L.S
        • Agre P
        Pathophysiology of the aquaporin water channels.
        Ann Rev Physiol. 1996; 58: 619-648
        • Nielsen S
        • Nagelhus E.A
        • Amiry-Moghaddam M
        • et al.
        Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain.
        J Neurosci. 1997; 17: 171-180
        • Huff A.L
        • Hupp S.L
        • Rothrock J.F
        Chronic daily headache with migrainous features due to papilledema-negative idiopathic intracranial hypertension.
        Cephalalgia. 1996; 16: 451-452
        • Marcelis J
        SD S: Idiopathic intracranial hypertension without papilledema.
        Arch Neurol. 1991; 48: 392-399
        • Mathew N.T
        • Ravishankar K
        • Sanin L.C
        Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
        Neurology. 1996; 46: 1226-1230
        • Friedman D.I
        • Ingram P
        • Campbell W.F
        Acetaminophen raises the cerebrospinal fluid pressure in Zucker rats.
        Neurology. 1999; 52: A23
        • Green J.P
        • Newman N.J
        • Stowe Z.N
        • et al.
        “Normal pressure” pseudotumor cerebri.
        J Neuroophthalmol. 1997; 17: 279
        • Barkana T
        • Levin N
        • Steiner I
        • et al.
        Pseudo-pseudotumor cerebri: idiopathic intracranial hypertension with pleocytosis. Presented at the Annual Meeting of the American Academy of Ophthalmology. Orlando, FL, 2003.
        American Academy of Ophthalmology, San Francisco2003 (p. 263)
        • Ireland B
        • Corbett J.J
        The search for causes of idiopathic intracranial hypertension.
        Arch Neurol. 1990; 47: 315-320
        • Wall M
        • Giuseffi V
        • Rojas P.B
        Symptoms and disease associations in pseudotumor cerebri: a case-control study.
        Neurology. 1989; 39: 210
        • McDonnell G.V
        • Patterson V.H
        • McKinstry S
        Cerebral venous thrombosis ocurring during an ectopic pregnancy and complicated by intracranial hypertension.
        Br J Clin Pract. 1997; 51: 194-197
        • Kikuchi M
        • Kudo S
        • Wada M
        • et al.
        Retropharyngeal rhabdomyosarcoma mimicking pseudotumor cerebri.
        Pediatr Neurol. 1999; 21: 496-499
        • Molina J.C
        • Martinez-Vea A
        • Riu S
        • et al.
        Pseudotumor cerebri: an unusual complication of brachiocephalic vein thrombosis associated with hemodialysis catheters.
        Am J Kidney Dis. 1998; 31: E3
        • Kollar D.C
        • Johnston I.H
        Pseudotumor after arteriovenous malformation embolisation.
        J Neurol Neurosurg Psychiatry. 1999; 67: 249
        • Condulis N
        • Germain G
        • Charest N
        • et al.
        Pseudotumor cerebri: a presenting manifestation of Addison's disease.
        Clin Pediatr. 1997; 36: 711-713
        • Friedman D.I
        • Streeten D.H.P
        Idiopathic intracranial hypertension and orthostatic edema may share a common pathogenesis.
        Neurology. 1998; 50: 1099-1104
        • Bourruat F.-X
        • Regli F
        Pseudotumor cerebri as a complication of amiodarone therapy.
        Am J Ophthalmol. 1993; 116: 776-777
        • Fort J.A
        • Smith L.D
        Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl.
        Ann Pharmacother. 1999; 33: 576-578
        • Greer M
        Benign intracranial hypertension.
        Neurology. 1963; 13: 439-441
        • Liu G.T
        • Kay M.D
        • Bienfang D.C
        • et al.
        Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease.
        Am J Ophthalmol. 1994; 117: 352-357
        • Walker A.E
        • Adamkiewitz J.J
        Pseudotumor cerebri associated with prolonged corticosteroid therapy.
        JAMA. 1964; 188: 779
        • Cruz O.A
        • Fogg S.G
        • Roper-Hall G
        Pseudotumor cerebri associated with cyclosporine use.
        Am J Ophthalmol. 1996; 122: 436-437
        • Blethen S.L
        Complications of growth hormone therapy in children.
        Curr Opin Pediatr. 1995; 7: 466-471
        • Francois I
        • Castells I
        • Silberstein J
        • et al.
        Empty sella, growth hormone deficiency and pseudotumour cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy.
        Eur J Pediatr. 1997; 156: 69-70
        • Koller E.A
        • Stadel B.V
        • Malozowski S.N
        Papilledema in 15 renally compromised patients treated with growth hormone.
        Pediatr Nephrol. 1997; 11: 451-454
        • Malozowski S
        • Tanner L.A
        • Wysowski D.K
        • et al.
        Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone.
        J Pediatr. 1995; 126: 996-999
        • Rogers A.H
        • Rogers G.L
        • Bremer D.L
        • et al.
        Pseudotumor cerebri in children receiving recombinant human growth hormone.
        Ophthalmology. 1999; 106: 1186-1189
        • Boot J.H
        Pseudotumor cerebri as a side effect of leuprorelin acetate.
        Ir J Med Sci. 1996; 165: 60
        • Campos S.P
        • Olitsky S
        Idiopathic intracranial hypertension after L-thyroxine therapy for acquired hypothyroidism.
        Clin Pediatr. 1995; 34: 334-337
        • Raghavan S
        • DiMartino-Nardi J
        • Saenger P
        • et al.
        Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism.
        J Pediatr. 1997; 130: 478-480
        • Saul R.F
        • Hamburger H.A
        • Selhorst J.B
        Pseudotumor cerebri secondary to lithium carbonate.
        JAMA. 1985; 253: 2869-2870
        • Cohen D.N
        Intracranial hypertension and papilledema associated with naladixic acid therapy.
        Am J Ophthalmol. 1973; 76: 680-682
        • Mukherjee A
        • Dutta B
        • Lahiri M
        • et al.
        Benign intracranial hypertension after naladixic acid overdose in infants.
        Lancet. 1990; 335: 1602
        • Alder J
        • Fraunfelder F
        • Edwards R
        • et al.
        Levonorgestrel implants and intracranial hypertension.
        N Engl J Med. 1995; 332: 1720-1721
        • Wysowski D.K
        • Green L
        Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch spontaneous reporting system.
        Obstet Gynecol. 1995; 85: 538-542
        • Gardner K
        • Cox T
        • Digre K
        Idiopathic intracranial hypertension associated with tetracycline use in fraternal twins: case report and review.
        Neurology. 1995; 45: 6-10
        • Giles C.L
        • Soble A.R
        Intracranial hypertension and tetracycline therapy.
        Am J Ophthalmol. 1971; 72: 981-982
        • Lee A.G
        Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne.
        Cutis. 1995; 55: 165-168
        • Maroon J.C
        • Mealy Jr., J
        Benign intracranial hypertension. Sequel to tetracycline therapy in a child.
        JAMA. 1971; 216: 1479-1480
        • Meacock D.J
        • Hewer R.L
        Tetracycline and benign intracranial hypertension.
        BMJ. 1981; 282: 1240
        • Minutello J.S
        • Dimayuga R.G
        • Carter J
        Pseudotumor cerebri, a rare adverse reaction to tetracycline therapy.
        J Periodontol. 1988; 58: 848-851
        • Ohlrich G.D
        • Ohlrich J.G
        Papilloedema in an adolescent due to tetracycline.
        Med J Aust. 1977; 1: 334-335
        • Pierog S.H
        • Al-Salihi F.L
        • Cinotti D
        Pseudotumor cerebri—a complication of tetracycline treatment of acne.
        J Adolesc Health. 1986; 7: 139-140
        • Quinn A.G
        • Singer S.B
        • Bunic J.R
        Pediatric tetracycline-induced pseudotumor cerebri.
        J AAPOS. 1999; 3: 53-57
        • Stuart B.H
        • Litt I.F
        Tetracycline-induced intracranial hypertension in an adolescent: a complication of systemic acne therapy.
        J Pediatr. 1978; 92: 679-680
        • Beran R.G
        Pseudotumor cerebri associated with minocycline therapy for acne.
        Med J Aust. 1980; 1: 323-324
        • Chiu A.M
        • Chuenkongkaew W.L
        • Cornblath W.T
        • et al.
        Minocycline treatment and pseudotumor cerebri syndrome.
        Am J Ophthalmol. 1998; 126: 116-121
        • Donnet A
        • Dufour H
        • Graziani N
        • et al.
        Minocycline and benign intracranial hypertension.
        Biomed Pharmacother. 1992; 46: 171-172
        • Moskowitz Y
        • Leibowitz E
        • Ronen M
        • et al.
        Pseudotumor cerebri induced by vitamin A combined with minocycline.
        Ann Ophthalmol. 1993; 25: 306-308
        • Lochhead J
        • Elston S.K
        Doxycycline induced intracranial hypertension.
        BMJ. 2003; 326: 641
        • Alemeyehu W
        Pseudotumor cerebri (toxic effect of the “magic bullet”).
        Ethiop Med. 1995; 33: 265
        • Feldman M.H
        • Schlezinger N.S
        Benign intracranial hypertension associated with hypervitaminosis A.
        Arch Neurol. 1970; 22: 1-7
        • Lombaert A
        • Carton H
        Benign intracranial hypertension due to A-hypervitaminosis in adults and adolescents.
        Eur Neurol. 1976; 14: 340-350
        • Bigby M
        • Stern R.S
        Adverse reactions to isotretinoin. A report for the Adverse Reaction Reporting System.
        J Am Acad Dermatol. 1988; 18: 543-552
      1. Fraunfelder FW, Fraunfelder FT, Corbett JJ. Isotretinoin usage and intracranial hypertension. Ophthalmology, in press

        • Fraunfelder F.W
        • Fraunfelder F.T
        • Edwards R
        Ocular side effects possibly associated with isotretinoin usage.
        Am J Ophthalmol. 2001; 132: 299-305
        • Lebowitz M.A
        • Berson D.S
        Ocular effects of oral retinoids.
        J Am Acad Dermatol. 1988; 19: 209-211
        • Roytman M
        • Frumkin A
        • Boyn T.G
        Pseudotumor cerebri caused by isotretinoin.
        Cutis. 1988; 42: 399-400
        • Bonnetblanc J.M
        • Hugon J
        • Dumas M
        • et al.
        Intracranial hypertension with etretinate.
        Lancet. 1983; 2: 974
        • Tallman M.S
        • Andersen J.W
        • Schiffer C.A
        • et al.
        Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.
        Blood. 2000; 95: 90-95
        • Viraben R
        • Mathieu C
        • Fontan B
        Benign intracranial hypertension during etretinate therapy for mycosis fungoides.
        J Am Acad Dermatol. 1985; 13: 515-517
        • Visani G
        • Manfroi S
        • Tosi P
        • et al.
        All-trans-retinoic acid and pseudotumor cerebri.
        Leuk Lymphoma. 1996; 23: 437-442
        • Javeed N
        • Shaikh J
        • Jayaram S
        Recurrent pseudotumor cerebri in an HIV-positive patient.
        AIDS. 1995; 9: 817-819
        • Prevett M.C
        • Plant G.T
        Intracranial hypertension and HIV associated meningoradiculitis.
        J Neurol Neurosurg Psychiatry. 1997; 62: 407-409
        • Schwartz S
        • Husstedt I.W
        • Georgiadis D
        • et al.
        Benign intracranial hypertension in an HIV-infected patient: headache as the only presenting sign.
        AIDS. 1995; 9: 657
        • Kan L
        • Sood S.K
        • Maytal J
        Pseudotumor cerebri in Lyme disease: a case report and literature review.
        Pediatr Neurol. 1998; 18: 439-441
        • Konrad D
        • Kuster H
        • Hunzinker U.A
        Pseudotumor cerebri after varicella.
        Eur J Pediatr. 1998; 157: 904-906
        • Lahat E
        • Leshem M
        • Barzilai A
        Pseudotumor cerebri complicating varicella in a child.
        Acta Paediatr. 1998; 87: 1310-1311
        • Kesler A
        • Ellis M.G
        • Reshef T
        • et al.
        Idiopathic intracranial hypertension and anticardiolipin antibodies.
        J Neurol Neurosurg Psychiatry. 2000; 68: 379-380
        • Leker R.R
        • Steiner I
        Anticardiolipin antibodies are frequently present in patients with idiopathic intracranial hypertension.
        Arch Neurol. 1998; 55: 817-820
        • Sussman J
        • Leach M
        • Greaves M
        • et al.
        Potentially pro-thrombotic abnormalities of coagulation in benign intracranial hypertension.
        J Neurol Neurosurg Psychiatry. 1997; 62: 229-233
        • Graham E.M
        • Al-Akshar R
        • Sanders M.D
        • et al.
        Benign intracranial hypertension in Behcet's syndrome.
        J Neuroophthalmol. 1980; 1: 73
        • Kalbian V.V
        • Challis M.T
        Behçet's disease: report of twelve cases with three manifesting as papilledema.
        Am J Med. 1970; 49: 823-829
        • Teh L.S
        • O'Connor G.M
        • O'Sullivan M.M
        • et al.
        Recurrent papilloedema and early onset optic atrophy in Behçet's syndrome.
        Ann Rheum Dis. 1990; 49: 410-411
        • Martinez-Lage J.F
        • Alamo L
        • Poza M
        Raised intracranial pressure in minimal forms of cranial synostosis.
        Childs Nerv Syst. 1999; 15: 11-15
        • Au Eong K.G
        • Hariharan S
        • Chua E.C
        • et al.
        Idiopathic intracranial hypertension, empty sella turcica and polycyctic ovary syndromes—a case report.
        Singapore Med J. 1997; 38: 129-130
        • Pelton R.W
        • Lee A.G
        • Orengo-Nania S.D
        • et al.
        Bilateral optic disk edema caused by sarcoidosis mimicking pseudotumor cerebri.
        Am J Ophthalmol. 1999; 127: 229-230
        • Miller J.J
        • Thomas D
        • Lynn J.L
        • et al.
        Sleep disorders: a risk factor for pseudotumor cerebri (PTC).
        Invest Ophthalmol Vis Sci. 2000; 41: S313
        • Purvin V.A
        • Kawasaki A
        • Yee R.D
        Papilledema and obstructive sleep apnea syndrome.
        Arch Ophthalmol. 2000; 118: 1626-1630
        • Wolin M.J
        • Brannon W.L
        Disk edema in an overweight woman (clinical conference).
        Surv Ophthalmol. 1995; 39: 307-314
        • Green L
        • Vinker S
        • Amital H
        • et al.
        Pseudotumor cerebri in systemic lupus erythematosis.
        Semin Arthritis Rheum. 1995; 25: 103-108
        • Horoshovski D
        • Amital H
        • Katz M
        • et al.
        Pseudotumor cerebri in SLE.
        Clin Rheumatol. 1995; 14: 708-710
        • Sybert V.P
        • Bird T.D
        • Salk D.J
        Pseudotumor cerebri and Turner syndrome.
        J Neurol Neurosurg Psychiatry. 1985; 48: 164-166
        • Seckl J
        • Lightman S
        Cerebrospinal fluid neurohypophysial peptides in benign intracranial hypertension.
        J Neurol Neurosurg Psychiatry. 1988; 51: 1538-1541
        • Sørenson P.S
        • Gjerris F
        • Hammer M
        Cerebrospinal fluid vasopressin and increased intracranial pressure.
        Neurology. 1982; 3: 1255
        • Sørenson P.S
        • Hammer M
        • Gjerris F
        Cerebrospinal fluid vasopressin in benign intracranial hypertension.
        Ann Neurol. 1984; 15: 435-440
        • Thibonnier M.J
        • Marchetti J.P
        • Corvol P.J
        • et al.
        Abnormal regulation of antidiuretic hormone in idiopathic edema.
        Am J Med. 1979; 67: 67
        • Sugarman H.J
        • Felton W.L
        • Salvant J.B
        • et al.
        Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity.
        Neurology. 1995; 45: 1655
        • Kupersmith M.J
        • Gamell L
        • Turbin R
        • et al.
        Effects of weight loss on the course of idiopathic intracranial hypertension in women.
        Neurology. 1998; 50: 1094-1098
        • Johnson L.N
        • Krohel G.B
        • Madsen R.W
        • et al.
        The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri).
        Ophthalmology. 1998; 105: 2313-2317
        • Tomsak R.L
        • Niffenegger A.S
        • Remler B.F
        Treatment of pseudotumor cerebri with Diamox (acetazolamide).
        J Clin Neuroophthalmol. 1988; 18: 93-98
        • Corbett J.J
        • Thompson H.S
        The rational management of idiopathic intracranial hypertension.
        Arch Neurol. 1989; 46: 1049-1051
        • Liu G.T
        • Glaser J.S
        • Schatz N
        High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri.
        Am J Ophthalmol. 1994; 118: 88-96
        • Friedman D.I
        • Eller P.E
        Topiramate for treatment of idiopathic intracranial hypertension.
        Headache. 2003; 43: 592
        • Keltner J.L
        Optic nerve sheath decompression. How does it work? Has its time come?.
        Arch Ophthalmol. 1988; 206: 1365-1369
        • Tsai J.C
        • Petrovich M.D
        • Sadun A.A
        Histological and ultractructural examination of optic nerve sheath decompression.
        Br J Ophthalmol. 1995; 79: 182-185
        • Hamed L.M
        • Tse D.T
        • Glaser J.S
        • et al.
        Neuroimaging of the optic nerve after fenestration for management of pseudotumor cerebri.
        Arch Ophthalmol. 1992; 110: 636-639
        • Mittra R.A
        • Sergott R.C
        • Flaharty P.M
        • et al.
        Optic nerve decompression improves hemodynamic parameters in papilledema.
        Ophthalmology. 1993; 100: 987-997
        • Lee S.Y
        • Shin D.H
        • Spoor T.C
        • et al.
        Bilateral retinal venous caliber decrease following unilateral optic nerve sheath decompression.
        Ophthalmic Surg. 1995; 6: 25-28
        • Carter S.R
        • Seiff S.R
        Macular changes in pseudotumor cerebri before and after optic nerve fenestration.
        Ophthalmology. 1995; 102: 937-941
        • Ngyun R
        • Carta A
        • Geleris A
        • et al.
        Long-term effect of optic sheath decompression on intracranial pressure in pseudotumor cerebri.
        Invest Ophthalmol Vis Sci. 1997; 38: S388
        • Hansen H
        • Helmke K
        Validation of optic nerve sheath response to changing cerebrospinal fluid pressure: ultrasound findings during intrathecal infusion.
        J Neurosurg. 1997; 87: 34-40
        • Pearson P.A
        • Baker R.S
        • Khorram D
        • et al.
        Evaluation of optic nerve sheath fenestration in pseudotumor cerebri using automated perimetry.
        Ophthalmology. 1991; 98: 99-105
        • Spoor T.C
        • Ramocki J.M
        • Madion M.P
        • et al.
        Treatment of pseudotumor cerebri by primary and secondary optic nerve sheasth decompression.
        Am J Ophthalmol. 1991; 112: 177-185
        • Anderson R.L
        • Flaharty R.M
        Treatment of pseudotumor cerebri by primary and secondary optic nerve sheath decompression.
        Am J Ophthalmol. 1992; 113 ([letter]): 599-601
        • Sergott R.C
        • Savino P.J
        • Bosley T.M
        Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri.
        Arch Ophthalmol. 1988; 106: 1384-1390
        • Kelman S.E
        • Sergott R.C
        • Cioffi G.A
        • et al.
        Modified optic nerve decompression in patients with functioning lumboperitoneal shunts and progressive visual loss.
        Ophthalmology. 1991; 98: 1449-1453
        • Mauriello J.A
        • Shaderowfsky P
        • Gizzi M
        • et al.
        Management of visual loss after optic nerve sheath decompression in patients with pseudotumor cerebri.
        Ophthalmology. 1995; 102: 441-445
        • Flynn W.J
        • Westfall C.T
        • Weisman J.S
        Transient blindness after optic nerve sheath fenestration.
        Am J Ophthalmol. 1994; 117: 678-679
        • Joos K.M
        • Mawn L.A
        • Shen J.H
        • et al.
        Chronic and acute analysis of optic nerve sheath fenestration with the free electron laser in monkeys.
        Lasers Surg Med. 2003; 32: 32-41
        • Cornblath W.T
        • Miller N.R
        Pseudotumor cerebri treated with lumbo-peritoneal shunt.
        Ann Neurol. 1989; 26: 183
        • Johnston I
        • Besser M
        • Morgan M
        Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension.
        J Neurosurg. 1988; 69: 195-202
        • Eggenberger E.R
        • Miller N.R
        • Vitale S
        Lumboperitoneal shunt for the treatment of pseudotumor cerebri.
        Neurology. 1996; 46: 1524-1530
        • Rosenberg M.L
        • Corbett J.J
        • Smith C
        • et al.
        Cerebrospinal diversion procedures for pseudotumor cerebri.
        Neurology. 1993; 43: 1071-1072
        • Burgett R.A
        • Purvin V.A
        • Kawasaki A
        Lumboperitoneal shunting for pseudotumor cerebri.
        Neurology. 1997; 49: 734-739
        • Howard J
        • Appen R
        Ventriculoperitoneal shunting for pseudotumor cerebri.
        Invest Ophthalmol Vis Sci. 2002; 43 (E-abstract 2461)
        • Lee A.G
        Visual loss as the manifesting symptoms of ventriculoperitoneal shunt malfunction.
        Am J Ophthalmol. 1996; 122: 127-129
        • Liu G.T
        • Volpe N.J
        • Schatz N.J
        • et al.
        Severe sudden visual loss caused by pseudotumor cerebri and lumboperitoneal shunt failure.
        Am J Ophthalmol. 1996; 122: 129-131
        • Alleyne Jr., C.H
        • Shutter L.A
        • Colohan A.R.T
        Cranial migration of a lumboperitoneal shunt catheter.
        South Med J. 1996; 89: 634-636
        • Miller N.R
        Bilateral visual loss and simultanagnosia after lumboperitoneal shunt for pseudotumor cerebri.
        J Neuroophthalmol. 1997; 17: 36-38
        • Johnston I.H
        • Sheridan M.M
        CSF shunting from the cisterna magna: a report of 16 cases.
        Br J Neurosurg. 1993; 7: 39-43
        • Huda-Baron R
        • Kupersmith M.J
        Idiopathic intracranial hypertension in pregnancy.
        J Neurol. 2002; 249: 1078-1081
        • Shapiro S
        • Yee R
        • Brown H
        Surgical management of pseudotumor cerebri in pregnancy: case report.
        Neurosurgery. 1995; 37: 829-831
        • Lessell S
        Pediatric pseudotumor cerebri (idiopathic intracranial hypertension).
        Surv Ophthalmol. 1992; 37: 155-166
        • Cinciripini G.S
        • Donahue S
        • Borchert M.S
        Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment and outcome.
        Am J Ophthalmol. 1999; 127: 178-182
        • Kesler A
        • Fattal-Valevski A
        Idiopathic intracranial hypertension in the pediatric population.
        J Child Neurol. 2002; 17: 745-748
        • Dhiravibulya K
        • Ouvrier R
        • Johnston I
        • et al.
        Benign intracranial hypertension in childhood; a review of 23 patients.
        J Paediatr Child Health. 1991; 27: 304-307
        • Baker R.S
        • Baumann R.J
        • Buncic J.R
        Idiopathic intracranial hypertension (pseudotumor cerebri) in pediatric patients.
        Pediatr Neurol. 1989; 5: 5-11
        • Baker R.S
        • Carter D.C
        • Hendrock E.B
        • et al.
        Visual loss in pseudotumor cerebri of childhood: a follow-up study.
        Arch Ophthalmol. 1985; 103: 1681-1686
        • Phillips P.H
        • Repka M.X
        • Lambert S.R
        Pseudotumor cerebri in children.
        J AAPOS. 1998; 2: 33-38
        • Speer C
        • Pearlman J
        • Phillips P.H
        • et al.
        Fourth cranial nerve palsy in pediatric patients with pseudotumor cerebri.
        Am J Ophthalmol. 1999; 127: 236-237
        • Schoeman J.F
        Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series.
        J Child Neurol. 1994; 9: 130-134